Latest news and press releases about Quantum-Si incorporated (QSI): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
Quantum-Si incorporated operates within the life sciences sector, focusing on the creation of an advanced platform for individual molecule detection. This innovative technology is designed to streamline sample preparation and subsequent sequencing processes. The company offers a unique, proprietary single molecule detection system that draws on advancements from the semiconductor industry.
Price
| Price | $0.73 |
| Market Cap | $144M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 0.88 |
| EV / EBITDA | -1.41 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | -47.12% |
| Return on Invested Capital | -51.82% |
| Return on Assets | -50.89% |
| Gross Margin | 35.02% |
| Operating Margin | -5929.72% |
| Net Margin | -6138.26% |
Related companies: ADCT · ALT · ANNX · AURA · AUTL · DBVT · ENGN
Explore sector: Healthcare · Medical - Devices
More sections of QSI: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks